Edition:
India

Neurotrope Inc (NTRP.OQ)

NTRP.OQ on NASDAQ Stock Exchange Capital Market

8.74USD
20 Apr 2018
Change (% chg)

$0.24 (+2.82%)
Prev Close
$8.50
Open
$8.56
Day's High
$8.74
Day's Low
$8.56
Volume
1,539
Avg. Vol
8,922
52-wk High
$20.50
52-wk Low
$3.41

Chart for

About

Neurotrope, Inc., formerly BlueFlash Communications, Inc., is a biopharmaceutical company with its product candidates in pre-clinical and clinical development. The Company is focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease (AD), which is in the... (more)

Overall

Beta: 3.38
Market Cap(Mil.): $40.11
Shares Outstanding(Mil.): 7.90
Dividend: --
Yield (%): --

Financials

BRIEF-Neurotrope's Bryostatin Improves Cognition In Patients

* NEUROTROPE'S BRYOSTATIN IMPROVES COGNITION IN PATIENTS WITH ADVANCED ALZHEIMER'S DISEASE BASED ON FURTHER ANALYSIS OF PHASE 2 CLINICAL TRIAL DATA Source text for Eikon: Further company coverage:

05 Jan 2018

BRIEF-Neurotrope Appoints Charles S. Ryan As CEO

* NEUROTROPE APPOINTS CHARLES S. RYAN AS CHIEF EXECUTIVE OFFICER

18 Dec 2017

Earnings vs. Estimates